Passed House — Oct 9, 2015
Last Action: On passage Passed by recorded vote: 261 - 159 (Roll no. 549).
Explanation: This bill passed in the House on October 9, 2015 and goes to the Senate next for consideration.
Nov 6, 1997
105th Congress, 1997–1998
This bill was introduced on November 6, 1997, in a previous session of Congress, but was not enacted.
Representative for Connecticut's 1st congressional district
Read Text »
Last Updated: Nov 6, 1997
Length: 3 pages
Provides that, if the Secretary of Health and Human Services or a carrier reduces a recognized rate for a drug or biological under part B (Supplementary Medical Insurance) of title ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 2851”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B .... Retrieved from https://www.govtrack.us/congress/bills/105/hr2851
“H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B ....” www.GovTrack.us. 1997. October 10, 2015 <https://www.govtrack.us/congress/bills/105/hr2851>
|title=H.R. 2851 (105th)
|accessdate=October 10, 2015
|author=105th Congress (1997)
|date=November 6, 1997
|quote=To prohibit application of a payment limit to a drug or biological under part B ...